TARGTEPO Treatment for Anemia in PD US Trial

Clinical trial NCT02468414 · TERMINATED

Trial details

NCT number: NCT02468414
Sponsor: Aevi Genomic Medicine, LLC, a Cerecor company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Anemia of End Stage Renal Disease

Start date: 2015-06-01
Primary completion: 2016-05-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.